Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 7, Pages 1901-1906
Publisher
Oxford University Press (OUP)
Online
2017-03-07
DOI
10.1093/jac/dkx094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis
- (2016) Danfeng Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis
- (2016) N. Lounis et al. MEDECINE ET MALADIES INFECTIEUSES
- Strength in Diversity: Hidden Genetic Depths of Mycobacterium tuberculosis
- (2016) Samantha L. Sampson TRENDS IN MICROBIOLOGY
- Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
- (2016) Eliza J. R. Peterson et al. Nature Microbiology
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of novel mutations associated with clofazimine resistance inMycobacterium tuberculosis: Table 1.
- (2015) Shuo Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Proportion of Heteroresistance ingyrAandgyrBin Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates
- (2014) Brandon Eilertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology
- (2014) Ekaterina N Chernyaeva et al. BMC GENOMICS
- Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene
- (2014) Z. Zhang et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
- (2014) C. Lange et al. EUROPEAN RESPIRATORY JOURNAL
- A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment: TABLE 1
- (2014) Akos Somoskovi et al. EUROPEAN RESPIRATORY JOURNAL
- Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China
- (2014) Zhijian Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- TMC207 becomes bedaquiline, a new anti-TB drug
- (2013) Juan Carlos Palomino et al. Future Microbiology
- Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent
- (2013) Madeleine Hanekom et al. PLoS One
- Variations of Subunit ε of the Mycobacterium tuberculosis F1FoATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207
- (2012) Goran Biuković et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- rplCT460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains
- (2012) Patrick Beckert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid, High-Throughput Detection of Rifampin Resistance and Heteroresistance in Mycobacterium tuberculosis by Use of Sloppy Molecular Beacon Melting Temperature Coding
- (2012) S. Chakravorty et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review
- (2012) Sophia B. Georghiou et al. PLoS One
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
- (2011) Katherine S. Long et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Canadian Multicenter Laboratory Study for Standardized Second-Line Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis
- (2011) M. Sharma et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mutations in 23S rRNA at the Peptidyl Transferase Center and Their Relationship to Linezolid Binding and Cross-Resistance
- (2010) K. S. Long et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning
- (2008) D. N. Wilson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system
- (2008) Anna Milano et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now